| License: Creative Commons Attribution 4.0 (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-402233
- DOI to cite this document:
- 10.5283/epub.40223
Abstract
Early osteoarthritis (OA), characterised by cartilage defects, is a degenerative disease that greatly affects the adult population. Cell-based tissue engineering methods are being explored as a solution for the treatment of these chondral defects. Chondrocytes are already in clinical use but other cell types with chondrogenic properties, such as mesenchymal stem cells (MSCs), are being ...
Owner only: item control page